{"timestamp": 1771594754.2672365, "value": {"ticker": "BRNS", "company_name": "Barinthus Biotherapeutics plc", "short_name": "Barinthus Biotherapeutics plc", "sector": "Healthcare", "industry": "Biotechnology", "country": "United Kingdom", "market_cap": 23681604, "float_shares": 36036870, "shares_outstanding": 40830353, "short_ratio": 0.03, "short_percent_of_float": 0.0001, "shares_short": 1434, "shares_short_prior": 7478, "insider_percent_held": 0.13372, "institution_percent_held": 0.409, "total_cash": 74272000, "total_debt": 11570000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 13.682, "current_ratio": 8.037, "book_value": 2.069, "price_to_book": 0.28032866, "operating_cashflow": -30651000, "free_cashflow": -16006000, "price": 0.58, "52w_high": 2.92, "52w_low": 0.56, "avg_volume": 60696, "avg_volume_10d": 51210, "full_time_employees": 105, "audit_risk": 0, "overall_risk": 0}}